Veterinary Medicines

Leventa 1 mg/ml oral solution for dogs

Authorised
  • Levothyroxine sodium
Download as PDF

Product identification

Medicine name:
LEVENTA 1MG/ML ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
Leventa 1 mg/ml oral solution for dogs
Active substance:
  • Levothyroxine sodium
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Levothyroxine sodium
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH03AA01
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • 30 mL amber glass bottle with a transparent LDPE insert and with a white HDPE child-resistant cap with tamper-proof closure in a printed carton. A 1 ml oral syringe graduated in 0.05 ml increments is supplied with the product. Pack size: 1 x 30 ml
  • 30 mL amber glass bottle with a transparent LDPE insert and with a white HDPE child-resistant cap with tamper-proof closure in a printed carton. A 1 ml oral syringe graduated in 0.05 ml increments is supplied with the product. Pack size: 6 x 30 ml
  • 30 mL amber glass bottle with a transparent LDPE insert and with a white HDPE child-resistant cap with tamper-proof closure in a printed carton. A 1 ml oral syringe graduated in 0.05 ml increments is supplied with the product. Pack size: 12 x 30 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 21904/14-03-2013/K-0162801
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0182/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."